Myeloproliferative Disorders in Pregnancy

被引：16
|
作者：
Harrison, Claire N. [1 ]
Robinson, Susan E. [1 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Guys Hosp, Dept Haematol, London SE1 9RT, England
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2011年 / 25卷 / 02期
关键词：
Myeloproliferative; Pregnancy; MPN; POLYCYTHEMIA RUBRA VERA; TYROSINE KINASE JAK2; ESSENTIAL THROMBOCYTHEMIA; ACTIVATING MUTATION; OPTIMAL MANAGEMENT; YOUNG-ADULTS; MYELOFIBROSIS; ASPIRIN; WOMEN; RISK;
D O I：
10.1016/j.hoc.2011.01.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This article reviews pregnancy outcome in women diagnosed with a myeloproliferative neoplasm (MPN), and discusses possible risk markers and the pathogenesis of poor pregnancy outcome. An outline of the key factors regarding the diagnosis and management of MPN in women of reproductive potential is followed by a description of the authors' management strategy for standard and high-risk pregnancy in MPN patients.
引用
收藏
页码：261 / +
页数：16
相关论文
共 50 条
  • [41] Cytogenetics of myeloproliferative disorders
    Bench, AJ
    Huntly, BJP
    Green, AR
    MOLECULAR BASIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS, 2004, : 28 - 37
  • [42] Chronic myeloproliferative diseases and pregnancy
    Tsvetaeva, N. V.
    Khoroshko, N. D.
    Sokolova, M. A.
    Shmakov, R. V.
    Semenova, E. A.
    Lopukhin, V. O.
    Romanova, E. A.
    Sudarikov, A. B.
    Vasilyev, S. A.
    Orel, E. B.
    Rudakova, V. E.
    Ivanova, V. L.
    Serebryanaya, L. A.
    T Sedova, G.
    Manakova, T. E.
    Tutaeva, V. V.
    Levina, A. A.
    Mamukova, Yu. I.
    TERAPEVTICHESKII ARKHIV, 2006, 78 (10) : 68 - 72
  • [43] Myelodysplastic and myeloproliferative disorders of childhood
    Hasle, Henrik
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 598 - 604
  • [44] IMMUNOLOGICAL DYSFUNCTION IN MYELOPROLIFERATIVE DISORDERS
    DIBELLA, NJ
    BROWN, GL
    CANCER, 1978, 42 (01) : 149 - 158
  • [45] JMML and other myeloproliferative disorders
    不详
    LEUKEMIA RESEARCH, 2006, 30 : S1 - S22
  • [46] AZATHIOPRINE IN MYELOPROLIFERATIVE AND AUTOIMMUNE DISORDERS
    TAGLIORETTI, D
    GIANGRANDE, A
    ACTA GENETICAE MEDICAE ET GEMELLOLOGIAE, 1968, 17 (01): : 258 - +
  • [47] BIOCHEMICAL MONITORING IN MYELOPROLIFERATIVE DISORDERS
    ROBERTS, BE
    COOPER, EH
    TURNER, R
    CHILD, JA
    JOURNAL OF CLINICAL PATHOLOGY, 1976, 29 (11) : 1048 - 1048
  • [48] REVERSE TRANSCRIPTION IN MYELOPROLIFERATIVE DISORDERS
    STRAYER, D
    BRODSKY, I
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 316 - 316
  • [49] THE PATHOGENESIS OF MYELOFIBROSIS IN MYELOPROLIFERATIVE DISORDERS
    GROOPMAN, JE
    ANNALS OF INTERNAL MEDICINE, 1980, 92 (06) : 857 - 858
  • [50] CHRONIC MYELOPROLIFERATIVE DISORDERS (CMPD)
    BURKHARDT, R
    BARTL, R
    JAGER, K
    FRISCH, B
    KETTNER, G
    MAHL, G
    SUND, M
    PATHOLOGY RESEARCH AND PRACTICE, 1984, 179 (02) : 131 - 186
12345